Accès gratuit
Numéro
Méd. Intensive Réa.
Volume 27, Numéro 3, Mai 2018
Infectieux
Page(s) 239 - 248
Section Mise au point / Update
DOI https://doi.org/10.3166/rea-2018-0048
Publié en ligne 19 juin 2018
  • Hayden A, Park S, Giustini D, Lee AYY, Chen LYC, (2016) Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: a systematic scoping review. Blood Rev 30: 411–420 [CrossRef] [PubMed] [Google Scholar]
  • Rivière S, Galicier L, Coppo P, Marzac C, Aumont C, Lambotte O, Fardet L, (2014) Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients. Am J Med 127: 1118–1125 [Google Scholar]
  • Ramos-Casals M, Brito-Zerón P, López-Guillermo A, Khamashta MA, Bosch X, (2014) Adult haemophagocytic syndrome. Lancet 383: 1503–1516 [CrossRef] [PubMed] [Google Scholar]
  • Fukaya S, Yasuda S, Hashimoto T, Oku K, Kataoka H, Horita T, Atsumi T, Koike T, (2008) Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford) 47: 1686–1691 [CrossRef] [PubMed] [Google Scholar]
  • Janka GE, Lehmberg K, (2013) Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematol Am Soc Hematol Educ Program 2013: 605–611 [Google Scholar]
  • Lykens JE, Terrell CE, Zoller EE, Risma K, Jordan MB, (2011) Perforin is a critical physiologic regulator of T-cell activation. Blood 118: 618–626 [Google Scholar]
  • Yang SL, Xu XJ, Tang YM, Song H, Xu WQ, Zhao FY, Shen DY, (2016) Associations between inflammatory cytokines and organ damage in pediatric patients with hemophagocytic lymphohistiocytosis. Cytokine 85: 14–17 [Google Scholar]
  • Krebs P, Crozat K, Popkin D, Oldstone MB, Beutler B, (2011) Disruption of MyD88 signalling suppresses hemophagocytic lymphohistiocytosis in mice. Blood 117: 6582–6588 [Google Scholar]
  • Rood JE, Rao S, Paessler M, Kreiger PA, Chu N, Stelekati E, Wherry EJ, Behrens EM, (2016) ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice. Blood 127: 426–435 [CrossRef] [Google Scholar]
  • Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G; for the Histiocyte Society, (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48: 124–131 [CrossRef] [PubMed] [Google Scholar]
  • Castillo L, Carcillo J, (2009) Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med 10: 387–392 [CrossRef] [PubMed] [Google Scholar]
  • Valade S, Azoulay E, Galicier L, Boutboul D, Zafrani L, Stepanian A, Canet E, Lemiale V, Venot M, Veyradier A, Mariotte E, (2015) Coagulation disorders and bleedings in critically ill patients with hemophagocytic lymphohistiocytosis. Medicine (Baltimore) 94: e1692 [CrossRef] [PubMed] [Google Scholar]
  • Strauss R, Neureiter D, Westenburger B, Wehler M, Kirchner T, Hahn EG, (2004) Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients: a postmortem clinicopathologic analysis: Crit Care Med 32: 1316–1321 [CrossRef] [PubMed] [Google Scholar]
  • Hayden A, Lin M, Park S, Pudek M, Schneider M, Jordan MB, Mattman A, Chen LYC, (2017) Soluble interleukin-2 receptor is a sensitive diagnostic test in adult HLH. Blood Adv 1: 2529–2534 [CrossRef] [PubMed] [Google Scholar]
  • Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, Coppo P, Hejblum G, (2014) Development and validation of the H-Score, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol 66: 2613–2620 [CrossRef] [PubMed] [Google Scholar]
  • Debaugnies F, Mahadeb B, Ferster A, Meuleman N, Rozen L, Demulder A, Corazza F, (2016) Performances of the H-Score for diagnosis of hemophagocytic lymphohistiocytosis in adult and pediatric patients. Am J Clin Pathol 145: 862–870 [CrossRef] [PubMed] [Google Scholar]
  • Allen CE, Yu X, Kozinetz CA, McClain KL, (2008) Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 50: 1227–1235 [CrossRef] [PubMed] [Google Scholar]
  • Nawathe PA, Ravindranath TM, Satwani P, Baird JS, (2013) Severe hemorrhagic coagulopathy with hemophagocytic lymphohistiocytosis secondary to Epstein-Barr virus-associated T-cell lymphoproliferative disorder. Pediatr Crit Care Med 14: e176–e181 [CrossRef] [PubMed] [Google Scholar]
  • de Kerguenec C, Hillaire S, Molinié V, Gardin C, Degott C, Erlinger S, Valla D, (2001) Hepatic manifestations of hemophagocytic syndrome: a study of 30 cases. Am J Gastroenterol 96: 852–857 [CrossRef] [Google Scholar]
  • Ost A, Nilsson-Ardnor S, Henter JI, (1998) Autopsy findings in 27 children with haemophagocytic lymphohistiocytosis. Histopathology 32: 310–316 [CrossRef] [PubMed] [Google Scholar]
  • Seguin A, Galicier L, Boutboul D, Lemiale V, Azoulay E, (2016) Pulmonary involvement in patients with hemophagocytic lymphohistiocytosis. Chest 149: 1294–1301 [CrossRef] [PubMed] [Google Scholar]
  • Anderson TL, Carr CM, Kaufmann TJ, (2015) Central nervous system imaging findings of hemophagocytic syndrome. Clin Imaging 39: 1090–1094 [CrossRef] [PubMed] [Google Scholar]
  • Aulagnon F, Lapidus N, Canet E, Galicier L, Boutboul D, Peraldi MN, Reuter D, Bernard R, Schlemmer B, Azoulay E, Zafrani L, (2015) Acute kidney injury in adults with hemophagocytic lymphohistiocytosis. Am J Kidney Dis 65: 851–859 [CrossRef] [PubMed] [Google Scholar]
  • Fardet L, Galicier L, Vignon-Pennamen MD, Regnier S, Noguera ME, de Labarthe A, Raffoux E, Martinez V, Buyse S, Viguier M, Osio A, Lebbé C, Morel P, Dupuy A, Rybojad M, (2010) Frequency, clinical features and prognosis of cutaneous manifestations in adult patients with reactive haemophagocytic syndrome. Br J Dermatol 162: 547–553 [CrossRef] [PubMed] [Google Scholar]
  • Lerolle N, Laanani M, Rivière S, Galicier L, Coppo P, Meynard JL, Molina JM, Azoulay E, Aumont C, Marzac C, Fardet L, Lambotte O, (2016) Diversity and combinations of infectious agents in 38 adults with an infection-triggered reactive haemophagocytic syndrome: a multicenter study. Clin Microbiol Infect 22: 268.e1–268.e8 [CrossRef] [Google Scholar]
  • Bal A, Mishra B, Singh N, Das A, Jindal S, (2009) Fulminant parvovirus B19-associated pancarditis with haemophagocytic lymphohistiocytosis in an immunocompetent adult. APMIS 117: 773–777 [CrossRef] [Google Scholar]
  • Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, Gould C, (2007) Infections associated with haemophagocytic syndrome. Lancet Infect Dis 7: 814–822 [CrossRef] [PubMed] [Google Scholar]
  • Daver N, McClain K, Allen CE, Parikh SA, Otrock Z, Rojas- Hernandez C, Blechacz B, Wang S, Minkov M, Jordan MB, La Rosée P, Kantarjian HM, (2017) A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer 123: 3229–3240 [CrossRef] [PubMed] [Google Scholar]
  • Buyse S, Teixeira L, Galicier L, Mariotte E, Lemiale V, Seguin A, Bertheau P, Canet E, de Labarthe A, Darmon M, Rybojad M, Schlemmer B, Azoulay E, (2010) Critical care management of patients with hemophagocytic lymphohistiocytosis. Intensive Care Med 36: 1695–1702 [CrossRef] [PubMed] [Google Scholar]
  • Nahum E, Ben-Ari J, Stain J, Schonfeld T, (2000) Hemophagocytic lymphohistiocytic syndrome: unrecognized cause of multiple organ failure. Pediatr Crit Care Med 1: 51–54 [CrossRef] [PubMed] [Google Scholar]
  • Larroche C, Bruneel F, André MH, Bader-Meunier B, Baruchel A, Tribout B, Genereau T, Zunic P; Comité d’évaluation et de diffusion des innovations technologiques (CEDIT), (2000) Intravenously administered gamma-globulins in reactive hemaphagocytic syndrome. Multicenter study to assess their importance, by the immunoglobulins group of experts of CEDIT of the AP–HP. Ann Med Interne (Paris) 151: 533–539 [PubMed] [Google Scholar]
  • Emmenegger U, Frey U, Reimers A, Fux C, Semela D, Cottagnoud P, Spaeth PJ, Neftel KA, (2001) Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. Am J Hematol 68: 4–10 [CrossRef] [PubMed] [Google Scholar]
  • Johnson TS, Terrell CE, Millen SH, Katz JD, Hildeman DA, Jordan MB, (2014) Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis. J Immunol 192: 84–91 [CrossRef] [PubMed] [Google Scholar]
  • Imashuku S, Kuriyama K, Teramura T, Ishii E, Kinugawa N, Kato M, Sako M, Hibi S, (2001) Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol 19: 2665–2673 [CrossRef] [PubMed] [Google Scholar]
  • Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL, (2011) How I treat hemophagocytic lymphohistiocytoses. Blood 118: 4041–4052 [CrossRef] [Google Scholar]
  • Wang Y, Huang W, Hu L, Cen X, Li L, Wang J, Shen J, Wei N, Wang Z, (2015) Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis. Blood 126: 2186–2192 [CrossRef] [Google Scholar]
  • Carcillo JA, Podd B, Simon DW, (2017) From febrile pancytopenia to hemophagocytic lymphohistiocytosis-associated organ dysfunction. Intensive Care Med 43: 1853–1855 [CrossRef] [PubMed] [Google Scholar]
  • Schram AM, Berliner N, (2015) How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood 125: 2908–2914 [CrossRef] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.